Literature DB >> 19925998

American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: the need to refine the BRONJ definition.

Giuseppe Colella, Giuseppina Campisi, Vittorio Fusco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19925998     DOI： 10.1016/j.joms.2009.07.097

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  29 in total

1.  Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.

Authors:  Johannes K-H Meier; Daniel Wolff; Steve Pavletic; Hildegard Greinix; Martin Gosau; Hartmut Bertz; Stefanie J Lee; Anita Lawitschka; Sharon Elad
Journal:  Clin Oral Investig       Date:  2010-09-22       Impact factor: 3.573

Review 2.  Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.

Authors:  Sabrina Crépin; Marie-Laure Laroche; Bernard Sarry; Louis Merle
Journal:  Eur J Clin Pharmacol       Date:  2010-05-01       Impact factor: 2.953

Review 3.  The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.

Authors:  Samantha Pozzi; Noopur Raje
Journal:  Oncologist       Date:  2011-04-14

Review 4.  Bisphosphonate-related osteonecrosis of the jaw: from the sine qua non condition of bone exposure to a non-exposed BRONJ entity.

Authors:  Valesca Sander Koth; Maria Antonia Figueiredo; Fernanda Gonçalves Salum; Karen Cherubini
Journal:  Dentomaxillofac Radiol       Date:  2016-05-31       Impact factor: 2.419

5.  Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.

Authors:  Matthew Cozin; Bradley M Pinker; Kimberley Solemani; Jeremy M Zuniga; Stephen C Dadaian; Serge Cremers; Regina Landesberg; Srikala Raghavan
Journal:  J Oral Maxillofac Surg       Date:  2011-07-31       Impact factor: 1.895

Review 6.  Adjudication of osteonecrosis of the jaw in phase III randomized controlled trials of denosumab: a systematic review.

Authors:  Paul de Boissieu; L Kanagaratnam; R Mahmoudi; A Morel; M Dramé; T Trenque
Journal:  Eur J Clin Pharmacol       Date:  2017-02-10       Impact factor: 2.953

7.  Legal liability in bisphosphonate-related osteonecrosis of the jaw.

Authors:  L Lo Russo; D Ciavarella; C Buccelli; O Di Fede; G Campisi; L Lo Muzio; G Pellegrino; P Di Lorenzo
Journal:  Br Dent J       Date:  2014-09       Impact factor: 1.626

8.  Cone beam computed tomography for diagnosis of bisphosphonate-related osteonecrosis of the jaw: evaluation of quantitative and qualitative image parameters.

Authors:  Roman Guggenberger; Emrah Koral; Wolfgang Zemann; Christine Jacobsen; Gustav Andreisek; Philipp Metzler
Journal:  Skeletal Radiol       Date:  2014-07-05       Impact factor: 2.199

Review 9.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567

10.  Onset of mandible and tibia osteoradionecrosis: a comparative pilot study in the rat.

Authors:  Monika Damek-Poprawa; Stefan Both; Alexander C Wright; Amit Maity; Sunday O Akintoye
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.